For the Inventor, By the Inventor

Enter assignee name

Venissieux, France

Flamel Technologies

Calculating rank

USPTO Granted Patents = 50

% Expired Patents = 40.0

CIPO Patents = 6

EPO Patents = 16

Trademarks = 1

Forward Citations = 1,428

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Remi Meyrueix (11 out of 17 patents)

Florence Guimberteau (9 out of 24 patents)

You-Ping Chan (9 out of 41 patents)

4. Gerard Soula (9 out of 61 patents)

5. Catherine Castan (9 out of 15 patents)

6. Gérard Soula (8 out of 14 patents)

7. Rémi Meyrueix (7 out of 10 patents)

8. Olivier Breyne (7 out of 22 patents)

9. Nathan J Bryson (6 out of 8 patents)

10. Olivier Soula (5 out of 33 patents)

11. Florence Nicolas (5 out of 5 patents)

12. Alain Constancis (4 out of 10 patents)

13. Rémi Soula (4 out of 6 patents)

14. Gerard Mignani (4 out of 41 patents)

15. Gilles Hugues Tapolsky (4 out of 4 patents)

Core Competencies:

Microcapsules

Modified Release

Oral Formulations

Therapeutic Applications

Anti-Misuse

Prolonged Release

Pharmaceutical Compositions

Colloidal Suspensions

Polyamino Acids

Galenical Forms

Aerosol Compositions

Biomaterials

50 patents: Sort by Forward Citations

1. 9233993 - N-phosphonomethylglycine guanidine derivative salts (2016-01-12),

2. 9023400 - Prolonged-release multimicroparticulate oral pharmaceutical form (2015-05-05),

3. 8895063 - Oral dosage form comprising an antimisuse system (2014-11-25),

4. 8821935 - Microcapsules with modified release of active principles with low solubility for oral delivery (2014-09-02),

5. 8734850 - Oral medicinal product with modified release of at least one active principle in multimicrocapsular form (2014-05-27),

6. 8679540 - Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications (2014-03-25),

7. 8652529 - Anti-misuse microparticulate oral pharmaceutical form (2014-02-18),

8. 8652523 - Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility (2014-02-18),

9. 8507003 - Compressed tablets comprising microcapsules with modified release (2013-08-13),

10. 8481019 - Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof (2013-07-09),

11. 8445023 - Anti-misuse microparticulate oral pharmaceutical form (2013-05-21),

12. 8293255 - Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes (2012-10-23),

13. 8236353 - Self-precipitating pharmaceutical formulations for the modified release of an active principle (2012-08-07),

14. 8206744 - Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications (2012-06-26),

15. 8197850 - Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same (2012-06-12),

Company Overview

Flamel Technologies, headquartered in Venissieux, France, specializes in the development and manufacturing of innovative pharmaceutical formulations. The company focuses on advanced technologies such as microencapsulation and modified release systems, which enhance the therapeutic efficacy of oral medications. Flamel's expertise extends to creating formulations that address anti-misuse and prolonged release, catering to diverse therapeutic applications. Their commitment to improving drug delivery systems positions them as a key player in the pharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

50 Patents

#1 in Venissieux

#478 in France

#14,036 in the World

Venissieux, France

Flamel Technologies

Forward Citations = 1,428

45 inventors:

Remi Meyrueix (11 out of 17 patents)

Florence Guimberteau (9 out of 24 patents)

You-Ping Chan (9 out of 41 patents)

4. Gerard Soula (9 out of 61 patents)

5. Catherine Castan (9 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Flamel Technologies. Retrieved from https://idiyas.com/company/flamel-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…